Welldoc Granted 25th US Patent, Expanding Company’s Platform Solution Capabilities

COLUMBIA, Md.--()--Welldoc®, a digital health leader revolutionizing chronic care, today announced that the company’s 25th patent was approved by the U.S. Patent and Trademark Office on December 8, 2021.

“Our twenty-fifth patent is an important milestone for Welldoc, signaling our industry leadership in translating the best of medical science into a digital health solution for chronic condition management,” said Kevin McRaith, President and CEO of Welldoc. “Our platform provides individuals with the autonomy and personalization to self-manage their chronic conditions. Welldoc understands the complexity of these conditions and is continually evolving our tech and AI-engine to connect the dots across multiple dimensions of health – activity, diet, psycho-social, labs, symptoms and medications – to provide the insights and data visualizations necessary to empower individuals and strengthen care team connections. Each patent awarded to Welldoc signifies an important layer of data, AI and clinical science that drives our award-winning comprehensive chronic care platform.”

Welldoc’s single platform provides a holistic, clinical-based approach for pre-diabetes, diabetes, hypertension, heart failure and behavioral health. By leveraging the power of data, AI and clinical science, individuals with chronic conditions receive real-time, personalized digital coaching to self-manage their health and better coordinate with health care providers in meeting their treatment goals.

About Welldoc®

Welldoc®, a digital health leader revolutionizing chronic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with chronic conditions, enabling improved health and outcomes. Welldoc’s comprehensive chronic care platform provides multi-condition support across diabetes, hypertension, heart failure and behavioral health. Welldoc’s flagship product, BlueStar®, an FDA-cleared digital health solution, guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. Welldoc partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs.

Contacts

MacDougall Advisors
Megan Prock McGrath
781-235-3060
mmcgrath@macdougall.bio

Release Summary

Welldoc announced that the company’s 25th patent was approved by the U.S. Patent and Trademark Office on December 8, 2021.

Contacts

MacDougall Advisors
Megan Prock McGrath
781-235-3060
mmcgrath@macdougall.bio